physics

Targeted alpha-particle therapy

Targeted alpha-particle therapy is a physics topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Targeted alpha-particle therapy rather than just read about it. In short: Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity.

Key takeaways

Targeted alpha-particle therapy belongs to physics; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Targeted alpha-particle therapy to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Targeted alpha-particle therapy from memory before moving on to harder problems.

Reference excerpt

Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point. It has been said that "α-emitters are indispensable with regard to optimisation of strategies for tumour therapy".

Advantages of alpha emitters

The primary advantage of alpha particle (α) emitters over other types of radioactive sources is their very high linear energy transfer (LET) and relative biological effectiveness (RBE). Beta particle (β) emitters such as yttrium-90 can travel considerable distances beyond the immediate tissue before depositing their energy, while alpha particles deposit their energy in 70–100 μm long tracks. Alpha particles are more likely than other types of radiation to cause double-strand breaks to DNA molecules, which is one of several effective causes of cell death.

Production Some α emitting isotopes such as 225Ac and 213Bi are only available in limited quantities from 229Th decay, although cyclotron production is feasible. Among alpha-emitting radiometals according to availability, chelation chemistry, and half-life, 212Pb is also a promising candidate for targeted alpha-therapy. The ARRONAX cyclotron can produce 211At by irradiation of 209Bi.

Applications Though many α-emitters exist, useful isotopes would have a sufficient energy to cause damage to cancer cells, and a half-life that is long enough to provide a therapeutic dose without remaining long enough to damage healthy tissue.

Immunotherapy Several radionuclides have been studied for use in immunotherapy. Though β-emitters are more popular, in part due to their availability, trials have taken place involving 225Ac, 211At, 212Pb and 213Bi.

Peritoneal carcinomas Treatment of peritoneal carcinomas has promising early results limited by availability of α-emitters compared to β-emitters.

Bone metastases 223Ra was the first α-emitter approved by the FDA in the United States for treatment of bone metastases from prostate cancer, and is a recommended treatment in the UK by NICE. In a phase III trial comparing 223Ra to a placebo, survival was significantly improved.

Leukaemia Early trials of 225Ac and 213Bi have shown evidence of anti-tumour activity in Leukaemia patients.

Melanomas Phase I trials on melanomas have shown 213Bi is effective in causing tumour regression.

Solid tumours The short path length of alpha particles in tissue, which makes them well suited to treatment of the above types of disease, is a negative when it comes to treatment of larger bodies of solid tumour by intravenous injection. Potential methods to solve this problem of delivery exist, such as direct intratumoral injection and anti-angiogenic drugs. Limited treatment experience of low grade malignant gliomas has shown possible efficacy.

See also Unsealed source radiotherapy Selective internal radiation therapy

References

Worked examples

Example 1 — a first encounter with Targeted alpha-particle therapy

Start with the simplest possible case. Write down what Targeted alpha-particle therapy claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In physics, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Targeted alpha-particle therapy before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Targeted alpha-particle therapy ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Targeted alpha-particle therapy

In research: Targeted alpha-particle therapy appears in physics research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Targeted alpha-particle therapy in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Targeted alpha-particle therapy is common in secondary-school and first-year university syllabi. It links to neighbouring topics Cancer treatments, Medical physics, Nuclear medicine, so understanding it makes those chapters shorter.
In everyday life: Look for Targeted alpha-particle therapy outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Targeted alpha-particle therapy” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Targeted alpha-particle therapy in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Targeted alpha-particle therapy means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Targeted alpha-particle therapy out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Targeted alpha-particle therapy in simple terms?

Why does Targeted alpha-particle therapy matter?

Because it connects several physics ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Targeted alpha-particle therapy?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Targeted alpha-particle therapy.